A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
Condition(s):Chronic Lymphocytic Leukemia; LeukemiaLast Updated:April 11, 2019Withdrawn
Hide Studies Not Open or Pending
Condition(s):Chronic Lymphocytic Leukemia; LeukemiaLast Updated:April 11, 2019Withdrawn
Condition(s):Chronic Myelogenous Leukemia, Ph1-Positive; Acute Myeloid Leukemia; Myelodysplastic SyndromeLast Updated:May 28, 2020Withdrawn
Condition(s):Breast Cancer; MetastasisLast Updated:March 15, 2011Completed
Condition(s):Leukemia, Myeloid, Chronic; Leukemia, Lymphocytic, Acute, L2Last Updated:February 8, 2010Completed
Condition(s):Advanced Breast CancerLast Updated:May 26, 2016Completed
Condition(s):Prostate CancerLast Updated:March 14, 2018Terminated
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:April 14, 2017Terminated
Condition(s):Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Core Binding Factor Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid LeukemiaLast Updated:March 1, 2023Completed
Condition(s):Leukemia, PediatricLast Updated:December 8, 2021Completed
Condition(s):Advanced Breast CancerLast Updated:March 24, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.